期刊： REVUE DE MEDECINE INTERNE, 2022; 43 (6)
Although being complex, suicide is a phenomenon considered as preventable, and its prevention has been made as a public health priority. Some interven......
期刊： REVUE DE MEDECINE INTERNE, 2022; 43 (10)
Introduction. - During placements, there is an opportunity to learn clinical skills and to assess their application. However, it represents two differ......
期刊： REVUE DE MEDECINE INTERNE, 2022; 43 (7)
Sarcoidosis can develop into a chronic disease in about 30% of cases. When general treatment is indicated, corticosteroids are the first-line treatmen......
期刊： REVUE DE MEDECINE INTERNE, 2022; 43 (11)
Systemic immunoglobulin light-chain (AL) amyloidosis is characterized by deposition of amyloid fibrils of light chains produced by clonal CD38 + plasm......
期刊： REVUE DE MEDECINE INTERNE, 2022; 43 (11)
Introduction. - Colchicine is a narrow therapeutic margin drug that does not have the adverse effects of corticosteroids and immunosuppressants. Its u......
期刊： REVUE DE MEDECINE INTERNE, 2022; 43 (2)
Meningiomas are the most frequent among intracranial tumors, and represent more than 30% of primitive central nervous system neoplasms. Arising from t......
期刊： REVUE DE MEDECINE INTERNE, 2022; 43 (3)
With aging worldwide population and the high incidence of cancer in the population of people over 75 years old, there is a need for oncologists and ge......
期刊： REVUE DE MEDECINE INTERNE, 2022; 43 (9)
Anti-cytokine antibodies (ACA) are an emerging cause of acquired immunodeficiency, especially in previously healthy adults. The most frequently report......
